Previous 10 | Next 10 |
2023-10-20 15:19:09 ET You have to neutralize positions when stocks are going bad, said Joe Terranova, chief market strategist for Virtus Investment Partners. He has sold his Invesco QQQ Trust ( NASDAQ: QQQ ) position after the profit and loss was “going the wrong way on ...
2023-10-19 03:12:00 ET Summary Drugmakers don’t have to dominate a healthcare portfolio. Equity investors should cast a wide net across the sector to find innovation and growth. When pharmaceutical companies conduct tests on new drugs, they typically outsource clinical tria...
2023-10-18 21:49:00 ET Summary After many years of Cumberland’s US Equity ETF portfolios being overweight in the healthcare sector, we are now at our lowest relative market weight for a long time. The economic benefits to the sector from the Covid pandemic are over. The...
2023-10-12 18:06:30 ET Summary September 2023 saw a surplus of $113B in the US domestic private sector, boosting financial balances. Bank credit creation showed signs of improvement, potentially signaling the start of a speculative credit creation boom. The US sectoral balance...
2023-10-10 07:16:00 ET Summary European countries have been plagued by a persistent medicine shortage for the past few years. Supply chain disruptions and increased demand are driving the shortfall. There are potential solutions; and one could involve breeding a whole lot more...
2023-10-06 18:09:48 ET Summary The biotechnology and pharmaceutical sectors have been under pressure in 2023, with the Invesco Pharmaceuticals ETF down 9% and the iShares Biotechnology ETF down 6%. Elevated interest rates and potential pricing power erosion are the primary headwin...
2023-10-03 12:08:04 ET More on Markets U.S. 10-Year Treasury yield tops 4.75% a level not seen since 2007 BlackRock is overweight AI, calling it a 'mega force' Berenberg: Get defensive with healthcare, utilities and telecoms Citi highlights Info Tech as an Ov...
2023-09-29 23:45:00 ET Summary A combination of public and private investments in neuroscience, government grants, and charitable donations are helping accelerate a wave of advancements and opportunities in neuroscience. Recent clinical trial success for the second significant, di...
2023-09-27 13:50:02 ET More on iShares Biotechnology ETF Biopharma Bounce-Back: From Policy Pains To Profitable Plains IBB: The Illness Of Idiosyncratic Risk BlackRock spotlights healthcare as an opportunity with recession talks in the air Seeking Alphaȁ...
2023-09-22 03:30:00 ET Summary Healthcare stocks often serve as powerful painkillers during market declines. While the MSCI World Index fell by 18.1% in 2022, healthcare stocks fell by only 5.4%. Investing effectively in healthcare stocks requires a unique set of skills. ...
News, Short Squeeze, Breakout and More Instantly...
iShares Biotechnology ETF Company Name:
IBB Stock Symbol:
NASDAQ Market:
2024-06-28 22:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-28 08:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...